A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.

Más betegség

• Any condition, unwillingness or inability which in the investigator's opinion might jeopardise participant's safety or compliance with the protocol.

Laborértékek

• HbA1c ≥ 6.5 percent (%) [48 milimol per mole (mmol/mol)] at screening.
• Any laboratory safety parameters at screening outside the below laboratory ranges:
  • Vitamin D (25-hydroxycholecalciferol) less than (<) 12 nanogram per mililiter (ng/mL) [30 nanometer (nM)] at screening
  • Parathyroid hormone (PTH) outside normal range at screening
  • Total calcium outside normal range at screening
  • Amylase ≥ 2 times upper limit of normal at screening
  • Lipase ≥ 2 times upper limit of normal at screening
  • Calcitonin ≥ 50 picogram per mililiter (pg/mL) at screening

• Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study.
• Male Chinese participants, age 18-55 years (both inclusive) at the time of signing the informed consent.
• Body mass index between 24.0 and 34.9 kg/m2 (both inclusive) at screening. Overweight and obesity should be due to excess adipose tissue, as judged by the investigator, with a body weight (more than or equal to) ≥ 65.0 kg at screening.
• Considered eligible based on the medical history, physical examination, and the results of vital signs, electrocardiogram and clinical laboratory tests performed during the screening visit, as judged by the investigator.